Contrary to claims of "socialized medicine," codifying President Trump's MFN policy prioritizes value over monopoly power.
Prescription Drugs
All Prescription Drugs
While Trump's strategy to lower prices is a step in the right direction, only Congress can deliver comprehensive reform that benefits all Americans
Attempts to lower drug prices leave intact a broken patent system that too often prioritizes profits over progress
The program has become a revenue-generating tool for hospitals rather than a mechanism to support low-income Americans
Exorbitant drug prices burden American patients and taxpayers in an unfree market
The PREVAIL Act would unnecessarily delay cheaper drugs from entering the market
Are Medicare’s drug pricing negotiations working?
One small change would give CMS the leverage to drive drug pricing down and improve costs for patients